Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

January 31, 2027

Conditions

Maturity Onset Diabetes of the Young

Interventions

DRUG

Liraglutide

Liraglutide will be prescribed following FDA approved packet insert for type 2 diabetes in our test population.

Trial Locations (1)

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

lead

Mansa

OTHER